Sumitomo Mitsui DS Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21M | Buy |
872,935
+10,557
| +1% | +$276K | 0.15% | 127 |
|
|
2026
Q1 | $24.2M | Buy |
862,378
+36,528
| +4% | +$972K | 0.2% | 102 |
|
|
2025
Q4 | $20.6M | Buy |
825,850
+5,501
| +0.7% | +$139K | 0.16% | 117 |
|
|
2025
Q3 | $20.9M | Buy |
820,349
+11,354
| +1% | +$280K | 0.17% | 111 |
|
|
2025
Q2 | $19.6M | Buy |
808,995
+27,043
| +3% | +$631K | 0.18% | 106 |
|
|
2025
Q1 | $19.8M | Buy |
781,952
+25,552
| +3% | +$669K | 0.2% | 93 |
|
|
2024
Q4 | $20.1M | Buy |
756,400
+52,578
| +7% | +$1.43M | 0.2% | 90 |
|
|
2024
Q3 | $20.4M | Buy |
703,822
+39,522
| +6% | +$1.15M | 0.22% | 87 |
|
|
2024
Q2 | $18.6M | Buy |
664,300
+18,674
| +3% | +$514K | 0.22% | 90 |
|
|
2024
Q1 | $17.9M | Buy |
645,626
+26,848
| +4% | +$745K | 0.22% | 88 |
|
|
2023
Q4 | $17.8M | Buy |
618,778
+9,032
| +1% | +$273K | 0.23% | 93 |
|
|
2023
Q3 | $20.2M | Buy |
609,746
+54,370
| +10% | +$1.92M | 0.31% | 66 |
|
|
2023
Q2 | $20.4M | Buy |
555,376
+76,883
| +16% | +$2.99M | 0.31% | 66 |
|
|
2023
Q1 | $19.5M | Buy |
478,493
+27,182
| +6% | +$1.17M | 0.35% | 60 |
|
|
2022
Q4 | $23.1M | Buy |
451,311
+25,238
| +6% | +$1.21M | 0.47% | 51 |
|
|
2022
Q3 | $18.6M | Buy |
426,073
+25,964
| +6% | +$1.26M | 0.43% | 52 |
|
|
2022
Q2 | $21M | Buy |
400,109
+24,001
| +6% | +$1.22M | 0.5% | 48 |
|
|
2022
Q1 | $19.5M | Buy |
376,108
+1,061
| +0.3% | +$55.1K | 0.41% | 56 |
|
|
2021
Q4 | $22.1M | Buy |
375,047
+15,076
| +4% | +$747K | 0.46% | 48 |
|
|
2021
Q3 | $15.5M | Sell |
359,971
-25,585
| -7% | -$1.13M | 0.37% | 62 |
|
|
2021
Q2 | $15.1M | Sell |
385,556
-814
| -0.2% | -$31.7K | 0.36% | 60 |
|
|
2021
Q1 | $14M | Buy |
386,370
+27,975
| +8% | +$993K | 0.37% | 63 |
|
|
2020
Q4 | $13.2M | Sell |
358,395
-20,826
| -5% | -$764K | 0.38% | 64 |
|
|
2020
Q3 | $13.2M | Sell |
379,221
-123,762
| -25% | -$4.34M | 0.42% | 57 |
|
|
2020
Q2 | $15.6M | Buy |
502,983
+10,860
| +2% | +$369K | 0.54% | 42 |
|
|
2020
Q1 | $15.2M | Buy |
492,123
+22,009
| +5% | +$750K | 0.63% | 38 |
|
|
2019
Q4 | $17.5M | Sell |
470,114
-71,780
| -13% | -$2.56M | 0.59% | 39 |
|
|
2019
Q3 | $18.5M | Buy |
541,894
+42,004
| +8% | +$1.53M | 0.69% | 34 |
|
|
2019
Q2 | $20.5M | Sell |
499,890
-84,279
| -14% | -$3.35M | 0.83% | 30 |
|
|
2019
Q1 | $23.5M | Buy |
584,169
+11,926
| +2% | +$478K | 0.39% | 76 |
|
|
2018
Q4 | $23.7M | Sell |
572,243
-7,074
| -1% | -$294K | 0.43% | 66 |
|
|
2018
Q3 | $24.2M | Sell |
579,317
-31,425
| -5% | -$1.21M | 0.37% | 73 |
|
|
2018
Q2 | $21M | Buy |
610,742
+17,267
| +3% | +$590K | 0.32% | 77 |
|
|
2018
Q1 | $20M | Sell |
593,475
-396
| -0.1% | -$13.6K | 0.3% | 81 |
|
|
2017
Q4 | $20.4M | Sell |
593,871
-4,412
| -0.7% | -$150K | 0.31% | 81 |
|
|
2017
Q3 | $20.3M | Sell |
598,283
-14,984
| -2% | -$482K | 0.32% | 80 |
|
|
2017
Q2 | $19.5M | Sell |
613,267
-36,197
| -6% | -$1.14M | 0.32% | 82 |
|
|
2017
Q1 | $21.1M | Buy |
649,464
+47,955
| +8% | +$1.51M | 0.36% | 76 |
|
|
2016
Q4 | $18.5M | Sell |
601,509
-16,328
| -3% | -$498K | 0.36% | 77 |
|
|
2016
Q3 | $19.9M | Sell |
617,837
-15,232
| -2% | -$509K | 0.43% | 66 |
|
|
2016
Q2 | $21.1M | Sell |
633,069
-65,729
| -9% | -$2.1M | 0.64% | 41 |
|
|
2016
Q1 | $19.7M | Buy |
698,798
+82,966
| +13% | +$2.37M | 0.61% | 40 |
|
|
2015
Q4 | $18.9M | Sell |
615,832
-260,392
| -30% | -$8.19M | 0.64% | 36 |
|
|
2015
Q3 | $26.1M | Buy |
876,224
+259,827
| +42% | +$8.33M | 0.89% | 19 |
|
|
2015
Q2 | $19.6M | Sell |
616,397
-40,153
| -6% | -$1.31M | 0.62% | 35 |
|
|
2015
Q1 | $21.7M | Sell |
656,550
-57,614
| -8% | -$1.83M | 0.66% | 30 |
|
|
2014
Q4 | $21.1M | Sell |
714,164
-50,105
| -7% | -$1.44M | 0.65% | 35 |
|
|
2014
Q3 | $21.4M | Sell |
764,269
-70,352
| -8% | -$1.97M | 0.66% | 36 |
|
|
2014
Q2 | $23.5M | Sell |
834,621
-232,261
| -22% | -$6.62M | 0.67% | 26 |
|
|
2014
Q1 | $32.5M | Sell |
1,066,882
-75,758
| -7% | -$2.26M | 0.96% | 16 |
|
|
2013
Q4 | $33.2M | Sell |
1,142,640
-54,868
| -5% | -$1.6M | 0.96% | 18 |
|
|
2013
Q3 | $32.6M | Sell |
1,197,508
-83,062
| -6% | -$2.26M | 0.93% | 18 |
|
|
2013
Q2 | $34M | Buy |
+1,280,570
| New | +$35.4M | 0.96% | 19 |
|
Other funds holding PFE
Sumitomo Mitsui DS Asset Management's PFE Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $276K and bringing the position to 872,935 shares worth $21M. The position accounts for 0.15% of the portfolio, ranked #127.
Sumitomo Mitsui DS Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $34M in Q2 2013. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 872,935 shares of Pfizer worth $21M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management bought 10,557 Pfizer shares in Q2 2026, an estimated $276K.
- Pfizer made up 0.15% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #127 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Sumitomo Mitsui DS Asset Management's Pfizer position peaked at $34M in Q2 2013.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.